Family Smoking Prevention and Tobacco Control Act Regulatory Research (93.077)
Family Smoking Prevention and Tobacco Control Act Regulatory Research (Assistance Listing 93.077) is run by the National Institutes of Health, part of the Department of Health and Human Services. It awarded $313 million in 176 grants from fiscal 2021 to 2025, about $1.8 million per award on average. 1 funding opportunity is open or forecast now.
The typical award was $664,484. Half of the 176 awards fell between $429,767 and $1.4 million, and they ranged from $20,039 to $20.7 million.
- Awarded, FY 2021 to 2025$313 million
- Grant awards176
- Typical award$664,484
- Awarded in FY 2025$54.9 million
- Size rank488 of 1,823
- Type of assistanceCooperative agreements, project grants, project grants (contracts), training
Key findings
- Annual funding fell from $72.6 million in fiscal 2021 to $54.9 million in fiscal 2025.
- It is the 488th largest of 1,823 federal grant programs by five-year awards.
- The 20 largest recipients received 82% of the money.
- Awards went to recipients in 35 states and territories.
What the program funds
The Family Smoking Prevention and Tobacco Control Act (TCA) provides the authority to regulate tobacco product manufacturing, distribution and marketing. Regulatory research will provide the scientific evidence to guide the implementation of this authority. Research areas include: 1) tobacco product composition and design 2), the toxicity of tobacco products, 3) addiction and abuse liability of tobacco products, 4) the short- and long-term health effects of tobacco products, 5) people’s behaviors related to tobacco product use and characteristics, 6) communicating to the public regarding nicotine and the health effects of tobacco products, 7) the influences of tobacco marketing on susceptibility and tobacco product use, and 8) the potential or actual impact of FDA regulatory actions. The strategic priorities for these research areas can be found at https://www.fda.gov/tobacco-products/research/research-priorities.
Forecast opportunities
Past notices
Of 14 notices posted under this program since 2021, most went up in March (4), November (4) and December (2).
- RFA-OD-25-008: Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
- RFA-OD-25-001: High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
- RFA-OD-23-021: Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
- RFA-OD-23-017: Tobacco Regulatory Science (R01 Clinical Trial Optional)
- RFA-OD-22-024: Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
- RFA-OD-22-025: Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
- RFA-OD-22-023: Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
- RFA-OD-22-026: Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
- RFA-OD-22-003: Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
- RFA-OD-22-004: Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
- RFA-OD-22-002: Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)
- RFA-OD-21-004: Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
- RFA-OD-21-003: Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
- RFA-OD-21-002: Tobacco Regulatory Science (R01 Clinical Trial Optional)
Rules from the program listing
Who can apply
Applicants should review the eligibility information in the individual funding opportunity announcements issued under this CFDA.
What the money can and cannot pay for
(1) Research project grants provide support for clearly defined projects or a small group of related research activities, and when appropriate, support of research conferences; (2) program project and center grants support large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus; (3) exploratory/development and clinical exploratory/developmental grants encourage the development of new research activities in categorical program areas; (4) cooperative agreements support single or a group of related research activities with significant involvement of federal staff; and (5) research training grants including fellowships and institutional training grants, career development grants and loan repayment contracts. Research must directly support the Family Smoking Prevention and Tobacco Control Act and the Center for Tobacco Products, Food and Drug Administration Research Priorities found at https://www.fda.gov/tobacco-products/research/research-priorities;
Matching requirements
This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Funding history and past recipients
From fiscal 2021 to 2025, Family Smoking Prevention and Tobacco Control Act Regulatory Research (93.077) awarded $313 million across 176 grant awards, an average of $1.8 million per award.
Who usually wins
Colleges and universities received 77% of the money, nonprofits 11% and businesses 4.7%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Colleges and universities | 135 | $241 million | 77% |
| Nonprofits | 27 | $34.5 million | 11% |
| Other | 12 | $22.7 million | 7.2% |
| Businesses | 2 | $14.7 million | 4.7% |
By state
25 states have a page for this program: those that received at least $1 million or 10 awards.
| State | Awards | Amount |
|---|---|---|
| California | 18 | $40.6 million |
| Connecticut | 11 | $29.0 million |
| North Carolina | 18 | $28.4 million |
| Pennsylvania | 14 | $27.2 million |
| Maryland | 6 | $23.9 million |
| Ohio | 12 | $21.0 million |
| Michigan | 3 | $20.3 million |
| New Jersey | 9 | $17.2 million |
| Kentucky | 5 | $16.9 million |
| New York | 17 | $16.1 million |
| Virginia | 5 | $10.0 million |
| Vermont | 2 | $9.3 million |
| Texas | 4 | $8.7 million |
| Massachusetts | 8 | $7.0 million |
| Georgia | 5 | $5.7 million |
| Florida | 3 | $4.8 million |
| Kansas | 2 | $3.9 million |
| Minnesota | 5 | $3.1 million |
| Nevada | 2 | $2.8 million |
| Illinois | 3 | $2.4 million |
| Wisconsin | 3 | $2.3 million |
| South Carolina | 2 | $2.3 million |
| Oklahoma | 2 | $1.4 million |
| New Mexico | 1 | $1.2 million |
| District of Columbia | 2 | $1.2 million |
| Nebraska | 2 | $876,268 |
| Indiana | 1 | $747,976 |
| Louisiana | 1 | $679,700 |
| West Virginia | 3 | $647,446 |
| Arkansas | 1 | $636,886 |
| Washington | 1 | $549,952 |
| New Hampshire | 1 | $492,397 |
| Oregon | 1 | $485,366 |
| Tennessee | 1 | $419,940 |
| Hawaii | 1 | $248,399 |